An updated cost-effectiveness analysis of axicabtagene ciloleucel in second-line large B-cell lymphoma patients in the United States
Journal of Medical Economics | December 6, 2023 | Volume: 27 | Issue: 1 | Pages: 77-83
10.1080/13696998.2023.2290832
| PMID 38053517